Good levels to buy TRVN

2020年11月17日

Very bullish for NASDAQ:TRVN in the long term.
- High demand product with blockbuster drug good for opiod crisis.
- Potential replacement for morphine, no real competitor
- Partnership with Syneos for sales
- Potential buyout

Good levels to buy at 2.50 and 2.33

Should see rise towards next quarter earnings.

Long term PTs
TP1 - $5
TP2 - $15
TP3 - $30

2020年12月8日

ノート

hold

2020年12月27日

ノート

Falling wedge pattern in the short term and an ascending triangle on the mid term.

Continue hold towards next quarter earnings in March

2021年1月6日

トレード稼働中

finance.yahoo.com/news/trevena-inc-provides-commercial-launch-120000483.html

2021年1月7日

ノート

Seems to breaking out of the falling wedge